# Opioids and Esophageal Function

> **NCT01012960** · PHASE4 · COMPLETED · sponsor: **Region Örebro County** · enrollment: 13 (actual)

## Conditions studied

- Pharyngeal Dysfunction
- Esophageal Dysfunction

## Interventions

- **DRUG:** methylnaltrexone

## Key facts

- **NCT ID:** NCT01012960
- **Lead sponsor:** Region Örebro County
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2011-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01012960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01012960, "Opioids and Esophageal Function". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01012960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*